MedTrace Logo

Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ryzodeg®

NCT02821052 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1355

Last updated 2019-10-15

No results posted yet for this study

Summary

This trial is conducted in Asia. The aim of this Non-interventional study is to investigate the long-term safety and effectiveness of Ryzodeg® (insulin degludec/insulin aspart) in Japanese patients with diabetes mellitus requiring insulin therapy under normal clinical practice conditions.

Conditions

Interventions

DRUG

insulin degludec/insulin aspart

Enrolled patients will be treated with Ryzodeg® under routine clinical practice.

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2018-11-24
Completion
2018-11-24

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02821052 on ClinicalTrials.gov